Skip to main content

and
  1. No Access

    Article

    A prospective observational study on the optimal maintenance strategy in HER2-positive advanced gastric cancer treated with trastuzumab-based therapy

    Trastuzumab plus chemotherapy is an effective therapy in HER2 positive advanced gastric cancer (AGC). However, the optimal maintenance treatment in patients benefited from the first line therapy remains unclear.

    Qian Li, Minzhi Lv, Huiqin Jiang, Yan Wang in Journal of Cancer Research and Clinical On… (2020)

  2. Article

    Open Access

    Analysis of UGT1A1*28 genotype and SN-38 pharmacokinetics for irinotecan-based chemotherapy in patients with advanced colorectal cancer: results from a multicenter, retrospective study in Shanghai

    The UGT1A1*28 polymorphism, although closely linked with CPT-11-related adverse effects, cannot be used alone to guide individualized treatment decisions. However, CPT-11 dosage can be adjusted according to m...

    Xun Cai, Weiguo Cao, Honghua Ding in Journal of Cancer Research and Clinical On… (2013)